Skip to content

Rehabilitation after a hip fracture: the effects of dietary protein and exercise on bone and muscle health and quality of life

Rehabilitation after a hip fracture: the effects of dietary protein and exercise on bone and muscle health and quality of life - ProBUS study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON49870
Enrollment
102
Registered
2019-02-01
Start date
2024-09-30
Completion date
Unknown
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Broken hip, Hip fracture Hip fracture

Interventions

There will be two groups, an intervention group receiving a tailor-made protein-enriched diet and an extended exercise training program, and a control group receiving usual care.

Sponsors

Wageningen Universiteit
Lead Sponsor

Eligibility

Age
65 Years to 99 Years

Inclusion criteria

Inclusion criteria: * Age >= 65 years * Acute hip fracture * Able to give written informed consent * Mentally competent, as judged by the treating physician * Admission to a rehabilitation centre that participates in this research

Exclusion criteria

Exclusion criteria: * Allergic, intolerant or hypersensitive to milk/lactose (self-reported) * Not willing to stop using dietary supplements with the exception of calcium  and vitamin D, or supplements prescribed by a physician.  * Pathological fracture or periprosthetic fracture * Abnormal hepatic or renal laboratory parameters, such as estimated glomerular  filtration rate (eGFR) <30 ml/min/1,73 m2 (data from hospital) * Diagnosis of disorders/diseases where a high protein intake can be harmful,  such as renal impairment or failure, or liver disease (elderly care physician  has the decisive voice). * Diagnosis of bone metabolic disorders such as primary hyperparathyroidism,  Paget*s disease, or myeloma  * Taking medication other than bisphosphonates known to strongly alter bone,  calcium or muscle metabolism, such as oestrogen, hormone replacement therapy,  corticosteroids, anabolic agents or calcitonin.  * Disorders/diseases which may affect ability to follow study protocol and  which cannot be overcome with help of a caregiver * Current participation in other scientific research  * No permission to request information from the general practitioner/ treating  specialist(s) about medical history, medication use, liver and kidney values,  and details about the broken hip

Design outcomes

Primary

MeasureTime frame
* Physical performance  

Secondary

MeasureTime frame
Muscle massBloodmarkers: P1NP, IGF-1, PTHLevels of (free) 25(OH)D, folate, vitamin B12, and vitamin CBone mineral density: total hip, femoral neck, and total bodyQuality of lifeInpatient rehabilitation timeDaily life functioningFear of falling

Countries

Netherlands

Contacts

Public ContactI Groenendijk

Wageningen Universiteit

inge.groenendijk@wur.nl0317-480100

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Jul 23, 2026